DnB Asset Management
RXRX icon

DnB Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History

DnB Asset Management’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.53M Buy
2025
Q2 		– Sell
2025
Q1 		$100K Sell
2024
Q4 		$577K Buy
2024
Q3 		– Sell
2024
Q2 		$248K Buy
2022
Q4 		– Sell
2022
Q3 		$277K Buy